Which treatment approaches are being investigated?
Several strategies are being explored: gene-based therapies (replacing, compensating or correcting for the faulty LAMA2 gene), protein replacement approaches (providing the missing laminin-alpha 2 protein), linker-protein therapies (specially designed proteins that compensate for the missing laminin alpha-2), anti-fibrosis strategies (reducing scarring in muscle tissue), and others.